These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9117087)

  • 21. The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
    Lin CW; Musacchio JM
    Mol Pharmacol; 1983 May; 23(3):558-62. PubMed ID: 6191190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.
    Barlow RB; Bond SM; Grant C; McQueen DS; Yaqoob Z
    Br J Pharmacol; 2001 Aug; 133(7):1087-95. PubMed ID: 11487520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
    Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
    Kam YL; Ro JY; Kim HJ; Choo HY
    Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of endogenous adenosine activity at adenosine receptors in guinea-pig ileum using a new pharmacological method.
    Nilsson KF; Grishina VA; Glaumann C; Gustafsson LE
    Acta Physiol (Oxf); 2010 Jun; 199(2):231-41. PubMed ID: 20121712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Main constituents of a commercial Drosera fluid extract and their antagonist activity at muscarinic M3 receptors in guinea-pig ileum.
    Kolodziej H; Pertz HH; Humke A
    Pharmazie; 2002 Mar; 57(3):201-3. PubMed ID: 11933852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the mechanism of action of peptide attacking smooth muscle. II. Differentiation of biologic activity of tachykinins in affinity and intrinsic efficacy].
    Bergmann J; Oehme P; Bienert M; Niedrich H
    Acta Biol Med Ger; 1975; 34(3):475-81. PubMed ID: 1189820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
    Lucchelli A; Santagostino-Barbone MG; Tonini M
    Br J Pharmacol; 1997 Aug; 121(8):1775-81. PubMed ID: 9283717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
    Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A
    J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New methods for determining dissociation constants of agonist-receptor complexes.
    Venter DP
    Eur J Pharmacol; 1996 May; 303(3):235-46. PubMed ID: 8813575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the use of a dynamic approach to the estimation of dissociation constants for reversible competitive antagonists.
    Amidon GL; Buckner CK
    J Pharmacol Exp Ther; 1981 Feb; 216(2):352-6. PubMed ID: 6257889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating activity of M1 receptor to the reaction of ileal smooth muscle.
    Glaza I; Szadujkis-Szadurski L; Szadujkis-Szadurski R; Gajdus M; Olkowska J
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():478-81. PubMed ID: 21918249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The assessment of antagonist potency under conditions of transient response kinetics.
    Christopoulos A; Parsons AM; Lew MJ; El-Fakahany EE
    Eur J Pharmacol; 1999 Oct; 382(3):217-27. PubMed ID: 10556673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced sensitivity of the iris sphincter to the muscarinic agonist carbachol at lower temperature.
    Patil PN
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):65-72. PubMed ID: 10048349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.
    Haddad EB; Patel H; Keeling JE; Yacoub MH; Barnes PJ; Belvisi MG
    Br J Pharmacol; 1999 May; 127(2):413-20. PubMed ID: 10385241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1996 Nov; 316(1):27-32. PubMed ID: 8982646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of competitive drug action at 5-hydroxytryptamine2 receptors in isolated rabbit aorta.
    Clancy BM; Osman R; Maayani S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):108-14. PubMed ID: 3612519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.